An Open-Label, Safety, Pharmacokinetic and Pharmacodynamic Study of Multiple Doses of GW786034 and Lapatinib Concomitantly Administered in Cancer Patients.

Trial Profile

An Open-Label, Safety, Pharmacokinetic and Pharmacodynamic Study of Multiple Doses of GW786034 and Lapatinib Concomitantly Administered in Cancer Patients.

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Mar 2011

At a glance

  • Drugs Lapatinib; Pazopanib
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 15 Oct 2008 Actual start date changed from Oct 2004 to Sep 2004 as reported by Clinicaltrials.gov.
    • 20 Aug 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
    • 10 Jul 2007 Status changed from recuiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top